|
Acknowledgments |
6 |
|
|
Preface |
8 |
|
|
References |
10 |
|
|
Contents |
12 |
|
|
Contributors |
16 |
|
|
The Neuropsychology Referral and Answering the Referral Question |
20 |
|
|
Evidenced Based Neuropsychological Practice |
22 |
|
|
Description of Neuropsychological Functioning |
23 |
|
|
Structure and Organization of the Evaluation |
23 |
|
|
References |
46 |
|
|
Deconstructing the Medical Chart |
57 |
|
|
The Medical Chart |
57 |
|
|
References |
76 |
|
|
Neuroanatomy Primer: Structure and Function of the Human Nervous System |
77 |
|
|
Introduction to the Human Nervous System |
81 |
|
|
The Central Nervous System |
83 |
|
|
Brain Anatomy Overview |
84 |
|
|
Cerebro-Spinal Fluid |
96 |
|
|
Spinal Cord |
99 |
|
|
Peripheral Nervous System (PNS) |
101 |
|
|
Cellular Organization of the Cortex |
118 |
|
|
Functional Neuroanatomy: Structural and Functional Networks |
124 |
|
|
Summary |
143 |
|
|
References and Suggested Readings |
144 |
|
|
Components of the Neuropsychological Evaluation |
145 |
|
|
Basics of the Neuropsychology Evaluation |
146 |
|
|
Factors Affecting Neuropsychological Functioning |
147 |
|
|
Time: An Important Variable in the Neuropsychological Evaluation |
148 |
|
|
Assessment of Basic Nervous System Functions (Cranial Nerves, Sensory and Motor Functions) |
148 |
|
|
“Higher Order” Neuropsychological Function Examination |
153 |
|
|
References and Suggested Further Readings |
155 |
|
|
Arousal: The Disoriented, Stuporous, Agitated or Somnolent Patient |
156 |
|
|
Arousal Problems: A Behavioral Guide |
157 |
|
|
Stuporous Conditions Mimicking Coma |
158 |
|
|
Delirium |
159 |
|
|
Assessment of Arousal |
161 |
|
|
References and Suggested Further Reading |
164 |
|
|
Attention/Concentration: The Distractible Patient |
165 |
|
|
Anatomy of Attention/Concentration |
166 |
|
|
Attention Problems: A Behavioral Guide |
167 |
|
|
Assessment of Attention |
170 |
|
|
Methods to Assess Attention and Concentration |
171 |
|
|
Brief/Bedside Assessment of Attention |
172 |
|
|
Assessment of Vigilance |
173 |
|
|
References and Suggested Further Reading |
174 |
|
|
Language Problems and Assessment: The Aphasic Patient |
175 |
|
|
Overview of Language |
176 |
|
|
Anatomical Correlates |
177 |
|
|
Recovery of Language Function |
183 |
|
|
Language Problems: A Behavioral Guide |
184 |
|
|
Bedside Assessment of Language |
190 |
|
|
Psychometric Based Assessment of Language |
191 |
|
|
References |
192 |
|
|
Appendix A |
193 |
|
|
Memory and Learning: The Forgetful Patient |
195 |
|
|
A Model of Memory |
196 |
|
|
Types of Memory |
198 |
|
|
Terms of Memory Impairment |
200 |
|
|
Neuropsychological Assessment of Memory Problems |
202 |
|
|
Anatomy of Memory |
205 |
|
|
Temporal Lobe and Memory |
206 |
|
|
Diencephalon and Memory |
206 |
|
|
Frontal Lobes and Basal Forebrain and Memory |
207 |
|
|
Laterality and Memory |
207 |
|
|
Storage and Retrieval in Memory |
208 |
|
|
Assessment of Memory |
209 |
|
|
Brief Bedside (Acute) Assessment of Memory |
210 |
|
|
Intermediate/Bedside Assessment of Memory |
210 |
|
|
Comprehensive/Outpatient Laboratory Assessment of Memory |
215 |
|
|
References and Suggested Further Reading |
215 |
|
|
Deficits in Visuospatial/Visuoconstructional Skills and Motor Praxis |
217 |
|
|
Anatomy of Visual and Visuospatial Processing |
218 |
|
|
Visual Processing “Streams” |
220 |
|
|
Visual and Visuospatial Deficits |
221 |
|
|
Visuoperceptual Distortions |
222 |
|
|
Cortical Blindness or “Blind Sight” |
222 |
|
|
Balint’s Syndrome |
222 |
|
|
Visual Agnosia |
224 |
|
|
Apraxia |
227 |
|
|
Assessment of Visuospatial (Visual-Spatial) Functioning |
228 |
|
|
Assessment and Interpretation of Visuoconstructional Functions |
230 |
|
|
Bedside Assessment of Visuospatial ( Visuoconstructional) Skills |
230 |
|
|
Laboratory (Outpatient) Neuropsychological Assessments |
233 |
|
|
References and Suggested Further Reading |
234 |
|
|
Frontal Lobe/Executive Functioning |
235 |
|
|
Anatomy of the Frontal Lobes |
236 |
|
|
Symptoms of Frontal Lobe Dysfunction: The “ Frontal Lobe” Patient |
243 |
|
|
Bedside Assessment of Frontal Lobe Functions |
256 |
|
|
References and Suggested Further Reading |
263 |
|
|
Affect, Emotions and Mood |
265 |
|
|
Multiaxial Diagnostic System |
266 |
|
|
Mood/Emotions and Neurologic Illness |
271 |
|
|
References and Suggested Further Reading |
281 |
|
|
Aphasia Syndromes |
282 |
|
|
Clinical Classification of Aphasias |
283 |
|
|
Assessment |
298 |
|
|
Ethnic, Age, Diversity and Psychiatric Considerations |
301 |
|
|
Appendix: Rapid Review Summary for Classic Aphasia Syndromes |
304 |
|
|
References |
306 |
|
|
Cerebrovascular Disease and Stroke |
308 |
|
|
Section I: Stroke Pathophysiology, Neuroanatomy, and Clinical Features |
309 |
|
|
Cerebral Vasculature |
319 |
|
|
Clinical Symptoms and Neuroanatomic Correlates |
324 |
|
|
Section II: Neuropsychological Assessment of Patients after Stroke |
355 |
|
|
Emotional Regulation/Personality Changes |
363 |
|
|
Treatment of Stroke and Rehabilitation |
365 |
|
|
References |
369 |
|
|
Dementias and Mild Cognitive Impairment in Adults |
372 |
|
|
Diagnostic Criteria and Definitions |
373 |
|
|
Etiologies of Dementia |
379 |
|
|
Prevalence of Dementia |
379 |
|
|
Clinical Descriptions of Common Dementia Conditions |
380 |
|
|
Assessment of Dementia |
412 |
|
|
References |
415 |
|
|
Episodic Neurologic Symptoms |
419 |
|
|
Global Symptoms |
420 |
|
|
Focal Symptoms |
429 |
|
|
References |
435 |
|
|
Epilepsy and Seizures |
437 |
|
|
Making a Diagnosis |
441 |
|
|
Incidence/Prevalence |
443 |
|
|
Seizure Classification |
444 |
|
|
Epilepsy Etiology and Syndromes |
451 |
|
|
Selected Epilepsy Syndromes |
452 |
|
|
Treatment of Seizures |
463 |
|
|
Neuropsychological (Cognitive and Behavioral) Comorbidity in Epilepsy |
471 |
|
|
Factors That May Obscure Neuropsychological Profiles in Presurgical Epilepsy Patients |
483 |
|
|
Predicting Seizure Freedom, Side of Seizure Onset, and Cognitive Outcome Following Epilepsy Surgery |
485 |
|
|
Psychiatric Status and Quality-of-life in Epilepsy |
496 |
|
|
Neuropsychological Assessment Guide |
501 |
|
|
Analysis of Change in Neuropsychology Test Scores |
507 |
|
|
Summary |
515 |
|
|
Appendix 1. International Classification of Epilepsies, Epileptic Syndromes, and Related Seizure Disorders |
516 |
|
|
Appendix 2. Example of Newly Proposed Classification of Epilepsy Syndromes ( 2001) |
518 |
|
|
References |
519 |
|
|
Neuropsychology of Psychogenic Nonepileptic Seizures |
534 |
|
|
Definition and Diagnosis |
536 |
|
|
Prevalence and Incidence |
539 |
|
|
Etiology |
541 |
|
|
Psychological Testing and Evidence-Based Psychology Practice |
546 |
|
|
Counting Elephants: Are There Meaningful PNES Subtypes? |
550 |
|
|
Treatment |
552 |
|
|
PNES in Children and Adolescents |
554 |
|
|
Neuropsychological Assessment Strategies with PNES |
554 |
|
|
Future Directions for Research, Detection, and Treatment of PNES |
556 |
|
|
Appendix |
556 |
|
|
References |
557 |
|
|
Somatoform Disorders, Factitious Disorder, and Malingering |
564 |
|
|
Definition/Terminology |
564 |
|
|
Prevalence |
566 |
|
|
Etiology |
566 |
|
|
Malingering and Factitious Disorder |
567 |
|
|
Differential Diagnosis: Distinguishing Somatoform Disorder from Malingering/ Factitious Conditions and Genuine Illness |
568 |
|
|
References |
574 |
|
|
Parkinson’s Disease and Other Movement Disorders |
579 |
|
|
Section I: Common Movement Disorders: Neurological and Neuropsychological Features |
580 |
|
|
Diffuse Lewy Body Disease/Dementia with Lewy Bodies |
590 |
|
|
“Parkinson’s Plus” Syndromes |
592 |
|
|
Drug-Induced Parkinsonism |
594 |
|
|
Vascular Parkinsonism |
595 |
|
|
Other Movement Disorders |
596 |
|
|
Section II: Medical and Surgical Treatment of the Movement Disorders |
601 |
|
|
Diffuse Lewy Body Disease/Lewy Body Dementia |
602 |
|
|
The “Parkinson’s Plus” Syndromes |
603 |
|
|
Presurgical Neuropsychological Evaluation |
608 |
|
|
Ablation Techniques |
609 |
|
|
The “Parkinson’s Plus” Syndromes |
613 |
|
|
Essential Tremor |
613 |
|
|
Essential Tremor |
636 |
|
|
Dystonia |
639 |
|
|
Tourette Syndrome |
647 |
|
|
Chapter Summary |
651 |
|
|
References |
651 |
|
|
Multiple Sclerosis and Other Demyelinating Disorders |
659 |
|
|
Clinical Features of Multiple Sclerosis |
661 |
|
|
Neuropsychological Symptoms of Multiple Sclerosis |
665 |
|
|
Correlates with Neuropsychological Deficits |
667 |
|
|
Assessment of Neuropsychological Deficits in MS |
669 |
|
|
Treatment Neuropsychological Deficits in MS |
670 |
|
|
References |
671 |
|
|
Moderate and Severe Traumatic Brain Injury |
674 |
|
|
Epidemiology |
675 |
|
|
Terminology and Classification Considerations |
676 |
|
|
Pathoanatomy and Pathophysiology |
678 |
|
|
Neurological and Neuropsychiatric Problems |
685 |
|
|
Functional and Neuropsychological Outcome |
691 |
|
|
Neuropsychological Assessment Issues |
694 |
|
|
Psychosocial Outcome |
695 |
|
|
Conclusions |
698 |
|
|
References |
699 |
|
|
Mild Traumatic Brain Injury |
708 |
|
|
Epidemiology of MTBI |
709 |
|
|
Terminology and Diagnostic Criteria |
709 |
|
|
Neuropsychological Outcome |
713 |
|
|
Early Intervention and Return to Work |
717 |
|
|
Depression and Mild TBI |
718 |
|
|
Mild Traumatic Brain Injury in the Military |
719 |
|
|
Conclusions |
722 |
|
|
References |
724 |
|
|
Sport-Related Concussion |
731 |
|
|
Neurobiology and Pathophysiology |
732 |
|
|
Recovery Time |
735 |
|
|
Classification Systems |
736 |
|
|
Multiple Concussions |
738 |
|
|
Emerging Evidenced-Based Neuropsychology |
739 |
|
|
Return to Play |
744 |
|
|
Conclusions |
748 |
|
|
References |
749 |
|
|
Post-Concussion Syndrome |
755 |
|
|
Diagnostic Criteria |
756 |
|
|
Diagnostic Challenges |
758 |
|
|
Factors Relating to the Perception and Reporting of Symptoms |
760 |
|
|
Post-Concussion Syndrome in Children |
765 |
|
|
Is the Post-Concussion Syndrome Caused by Brain Damage? |
767 |
|
|
Conclusions |
767 |
|
|
References |
768 |
|
|
Definition and Prevalence of Pediatric TBI |
774 |
|
|
Pediatric Traumatic Brain Injury (TBI): Overview |
774 |
|
|
Symptoms of TBI |
776 |
|
|
Differences Between Pediatric TBI and Adult TBI |
778 |
|
|
Neuropsychological Assessment of Pediatric TBI |
779 |
|
|
Proposed Neuropsychological Assessment Protocol ( Clinical/ Research:) |
781 |
|
|
Outcome and Recovery from TBI |
783 |
|
|
Variables Affecting Outcome and Recovery |
787 |
|
|
Management and Rehabilitation Issues |
788 |
|
|
Conclusions |
791 |
|
|
References |
791 |
|
|
Brain Tumors |
796 |
|
|
Types of Tumors |
797 |
|
|
Epidemiology |
799 |
|
|
Signs and Symptoms |
800 |
|
|
Diagnosis and Neuroimaging |
802 |
|
|
Classification and Survival Rates |
803 |
|
|
Treatment |
806 |
|
|
Neuropsychological Assessment Issues |
808 |
|
|
Summary and Conclusions |
814 |
|
|
References |
815 |
|
|
Neurotoxicity in Neuropsychology |
821 |
|
|
Definitions |
822 |
|
|
Principals of Identifying and Evaluating Neurotoxic Exposure |
828 |
|
|
The Neurotoxicity Syndrome |
832 |
|
|
Assessment for Neurotoxicity |
834 |
|
|
References |
842 |
|
|
Cognitive Decline in Childhood or Young Adulthood |
847 |
|
|
Metabolic Diseases |
849 |
|
|
Acute Disseminated Encephalomyelitis (ADEM) |
855 |
|
|
Rassmussen’s Encephaolpathy |
856 |
|
|
Vitamin B12 Deficiency (Cobalamin Disorders) |
858 |
|
|
Galactosemia |
859 |
|
|
Hallervorden-Spatz Syndrome |
860 |
|
|
Rett Syndrome |
860 |
|
|
Hydrocephalus |
861 |
|
|
Psuedotumor Cerebri (Idiopathic Intracranial Hypertension) |
863 |
|
|
Sickle Cell Disease |
864 |
|
|
Lafora Disease (Aka Lafora Progressive Myoclonic Epilepsy) |
865 |
|
|
HIV Associated Progressive Encephalopathy (HPE)/HIV-Associated Neurocognitive Disorders |
866 |
|
|
Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy ( CADISIL) |
867 |
|
|
Wilson’s Disease (Hepatolenticular Degeneration) |
867 |
|
|
References |
868 |
|
|
Application of Motivational Interviewing to Neuropsychology Practice: A New Frontier for Evaluations and Rehabilitation |
870 |
|
|
A New Approach to Noncompliance and Patient Feedback: Emerging Empirical Support |
871 |
|
|
What Is Motivational Interviewing? |
872 |
|
|
Core Concepts and Principles of MI |
873 |
|
|
Transtheoretical Model of Change |
873 |
|
|
Principles and SPIRIT of MI |
874 |
|
|
MI Skills and Examples of Strategies |
875 |
|
|
Summary |
877 |
|
|
References |
877 |
|
|
Reliability and Validity in Neuropsychology |
879 |
|
|
Reliability in Neuropsychology |
880 |
|
|
Internal Reliability |
881 |
|
|
Test–Retest Reliability |
884 |
|
|
Alternate Form Reliability |
885 |
|
|
Interrater Reliability |
886 |
|
|
Evaluating a Test’s Reliability |
888 |
|
|
Limits to Reliability, Practice Effects, and Effects of Prior Exposure |
889 |
|
|
Validity in Neuropsychology |
892 |
|
|
Validity Models |
892 |
|
|
How to Evaluate the Validity of a Test |
893 |
|
|
Conclusions |
896 |
|
|
References |
897 |
|
|
Psychometric Foundations for the Interpretation of Neuropsychological Test Results* |
899 |
|
|
Interpreting and Communicating Test Performance in Clinical Practice |
900 |
|
|
Sample Characteristics and Test Score Interpretation |
902 |
|
|
Comparing Scores Between Tests |
909 |
|
|
Normal Variability across Test Batteries and the Prevalence of Low Scores |
913 |
|
|
Assessing Change over Time |
915 |
|
|
Summary and Conclusions |
924 |
|
|
References |
926 |
|
|
Improving Accuracy for Identifying Cognitive Impairment |
929 |
|
|
Conceptualizing Cognitive Impairment |
930 |
|
|
Classifying Cognitive Impairment |
932 |
|
|
DSM-IV Cognitive Disorder NOS ( Mild Neurocognitive Disorder) |
934 |
|
|
Evaluating Cognitive Impairment: Five Psychometric Principles to Consider |
935 |
|
|
Identifying Cognitive Impairment: New Psychometric Criteria for Cognitive Disorder NOS |
946 |
|
|
Conclusions |
951 |
|
|
References |
953 |
|
|
Index |
957 |
|